![Charlotte Antonsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Charlotte Antonsen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
BI Technology A/S
![]() BI Technology A/S Investment ManagersFinance BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark.
7
| Extinct | Investment Managers | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Charlotte Antonsen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Director/Board Member Director/Board Member | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Technical University of Denmark | College/University | Graduate Degree Corporate Officer/Principal | |
Roche Innovation Center Copenhagen A/S
![]() Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Warren Pharmaceuticals, Inc.
![]() Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Aarhus | College/University | Corporate Officer/Principal Graduate Degree | |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Chairman Chairman | |
Bankinvest Biomedical Venture
![]() Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
TopoTarget UK Ltd.
![]() TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Chairman | |
Meabco A/S
![]() Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Henley Management College | College/University | Masters Business Admin | |
Novo Ventures 1 A/S
![]() Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
ORPHAZYME A/S | Pharmaceuticals: Major | Chief Executive Officer | |
BioStratum, Inc.
![]() BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
WoB Holding ApS
![]() WoB Holding ApS Financial ConglomeratesFinance WoB Holding ApS is an investment holding Danish company. The private company is based in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Dansk Biotek
![]() Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
InnovationsFonden
![]() InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal | |
Oz Holding ApS
![]() Oz Holding ApS Financial ConglomeratesFinance Oz Holding ApS provides investment services. | Financial Conglomerates | Director/Board Member | |
Vico Therapeutics BV
![]() Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Muna Therapeutics ApS
![]() Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Chief Operating Officer | |
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
GENMAB A/S | Pharmaceuticals: Major | Chairman | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
CliniGenetics SA
![]() CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Adenovir Pharma AB
![]() Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
PM Equity Partner SARL
![]() PM Equity Partner SARL Investment ManagersFinance PM Equity Partner SARL (PMEP) is a venture capital arm of Philip Morris International, Inc. which was founded in 2015. The firm is headquartered in Lausanne, Switzerland. | Investment Managers | Private Equity Investor | |
Pharmacia AB /Hillerod Unit/
![]() Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Karolinska Institutet | College/University | Graduate Degree | |
INZILE AB (PUBL) | Motor Vehicles | Director/Board Member | |
Frigoscandia AB
![]() Frigoscandia AB Air Freight/CouriersTransportation Frigoscandia AB offers national and international transport and warehousing services. The firm provides thermally-regulated logistics services. It engages in shipping and storage of fresh, chilled and frozen goods from the producer to the Nordic area and the rest of the world. The company was founded in 1948 and is headquartered in Helsingborg, Sweden. | Air Freight/Couriers | Chairman | |
Intomics A/S
![]() Intomics A/S Miscellaneous Commercial ServicesCommercial Services Intomics A/S provides data analysis solutions to data intensive research projectsa. Its services include advisory service, data analysis, and knowledge management. The firm helps clients in the pharmaceutical industry discover novel and drug targets, identify innovative and discriminative biomarkers, and enhance understanding of the underlying disease-biology at molecular level. The company was founded by Soren Brunak, Kasper Lage, Rasmus Wernersson and Thomas Skot Jensen in 2008 and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Dänemark | 25 |
Schweden | 9 |
Vereinigtes Königreich | 6 |
Vereinigte Staaten | 5 |
Schweiz | 3 |
Sektoral
Health Technology | 22 |
Finance | 9 |
Consumer Services | 6 |
Commercial Services | 6 |
Distribution Services | 3 |
Operativ
Director/Board Member | 27 |
Chairman | 12 |
Corporate Officer/Principal | 11 |
Private Equity Investor | 9 |
Chief Executive Officer | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Anders Hinsby | 14 |
Jesper Zeuthen | 13 |
Thomas Tscherning | 13 |
Jens W. Kindtler | 9 |
Björn Dellgren | 7 |
Jan Honoré | 6 |
Linda Sjöström | 6 |
- Börse
- Insiders
- Charlotte Antonsen
- Unternehmensverbindungen